Oral delivery of purified lipoprotein OspA protects mice from systemic infection with Borrelia burgdorferi

By Luke C.J.   Huebner R.C.   Kasmiersky V.   Barbour A.G.  

Vaccine, Vol. 15, Iss. 6, 1997-04 ,pp. : 739-746

Elsevier

Access to resources Recommend Favorite

OspA lipoprotein of Borrelia burgdorferi is a mucosal immunogen and adjuvant

By Erdile L.F.   Guy B.  

Vaccine, Vol. 15, Iss. 9, 1997-06 ,pp. : 988-995

Elsevier

Access to resources Recommend Favorite

The Lyme disease vaccine candidate outer surface protein A (OspA) in a formulation compatible with human use protects mice against natural tick transmission of B. burgdorferi

By Golde W.T.   Burkot T.R.   Piesman J.   Dolan M.C.   Capiau C.   Hauser P.   Dequesne G.   Lobet Y.  

Vaccine, Vol. 13, Iss. 5, 1995-01 ,pp. : 435-441

Elsevier

Access to resources Recommend Favorite

Vaccination against Lyme Disease with recombinant Borrelia burgdorferi outer-surface protein A (rOspA) in horses

By Chang Y.-F.   Novosol V.   McDonough S.P.   Chang C.-F.   Jacobson R.H.   Divers T.   Quimby F.W.   Shin S.   Lein D.H.  

Vaccine, Vol. 18, Iss. 5, 1999-10 ,pp. : 540-548

Elsevier

Access to resources Recommend Favorite

Safety and immunogenicity of recombinant Bacille Calmette-Guerin (rBCG) expressing Borrelia burgdorferi outer surface protein A (OspA) lipoprotein in adult volunteers: a candidate Lyme disease vaccine

By Edelman R.   Palmer K.   Russ K.G.   Secrest H.P.   Anna L. Becker J.   Bodison S.A.   Perry J.G.   Sills A.R.   Barbour A.G.   Luke C.J.   Hanson M.S.   Stover C.K.   Burlein J.E.   Bansal G.P.   Connor E.M.   Koenig S.  

Vaccine, Vol. 17, Iss. 7, 1999-02 ,pp. : 904-914

Elsevier

Access to resources Recommend Favorite